DNP- 10 Strategic Points

I need help to fix my DNP 10 Strategic Points. I have attached my original with the Professor’s feedback for what needs to be corrected in it. Please see my school’s Template attached and another one that is already completed by another student to use to update mine.

The 10 Strategic Points for the Prospectus and Direct Practice Improvement Project

Introduction

In the Direct Practice Improvement (DPI) Project, there are 10 key or strategic points that need to be clear, simple, correct, and aligned to ensure the project is doable, valuable, and credible. These points, which provide a guide or vision for the project. The 10 Strategic Points are defined within this document and a template provided. The ten strategic points are developed in a table format, as noted below.

The Process for Defining the 10 Strategic Points

The order of the 10 Strategic points listed below reflects the order in which the learner completes the work product. The first five strategic points focus primarily on defining the purpose or focus for the project based on a clearly defined need or gap from the project site.

Criteria for Evaluating the 10 Strategic Points: Clear, Simple, Correct, and Aligned

When developing a project, it is important to define the 10 Strategic points, so they are simple, clear, and correct in order to ensure that anyone who reviews them will easily understand the quality improvement project. It is important to align all of the 10 Strategic points to ensure it will be possible to conduct and complete the project.

Developing the 10 Strategic Points document begins in DNP-815A begins as a three-page document that can help ensure clarity, simplicity, correctness, and alignment of each of these 10 Strategic Points in the Direct Practice Improvement Project. This document is integral to learner success in the project courses. Therefore constant updates should be made through each course as you develop the project. Please see the table below regarding the development of the citation requirements expected per course.

CourseMinimal number of articlesDNP-801ABegin collecting original research to support the evidence-based practice intervention found in the research or clinical practice guidelines.MUST have 2 original research articles from the USA (or Canada if Canadian student) to support the intervention within five years of your graduation date.DNP-815AMust have a total of 5 original research articles:MUST have 2 original research articles from the USA (or Canada if Canadian student)to support the intervention within five years of your graduation date. Other 3 research articles may be added from US, Canada, UK, Denmark, India, New Zealand, Germany, or Australia.DNP-820AMust have a total of 15 original research articles:MUST have 2 original research articles from the USA (or Canada if Canadian student) to support the intervention within five years of your graduation date. Other 3 research articles may be added from US, Canada, UK, Denmark, India, New Zealand, Germany, or Australia.Any other original research can come from any of the 131 countries listed in the International Compilation of Human Research Standards 2020) found here:https://www.hhs.gov/ohrp/international/compilation-human-research-standards/index.htmlDNP-830 (A)These points should have been completed and ready for use in DNP-830A to support the drafting of the DPI project. All criteria from DNP-820A should have been met and revised.

Value of the 10 Strategic Points Document

The document can be used to review the proposed project with the people or organizations from whom learners need to gain permission to conduct their project, a critical step required before learners can implement their DPI project. The document also proves useful for communicating the DPI project focus with the Content Expert, as well as for reviewing the DPI project with the Project Chair, mentor, content expert, and academic quality review (AQR) process. (Delete all of the information above when submitting the document as to keep the GCU logo)

Example: 10 Strategic Points Document for a Quality Improvement Project

Ten Strategic Points

The 10 Strategic PointsTitle of Project1) Title of ProjectList the title of the project/manuscript to include the intervention and no more than 12 wordsBackgroundTheoretical FoundationLiterature SynthesisPractice Change Recommendation2) Background to Chosen Evidence-Based Intervention:List the primary points for six sections.i) Background of the practice problem/gap at the project siteii) Significance of the practice problem/gap at the project siteiii) Theoretical Foundations (choose one nursing theory and one evidence-based change model to be the foundation for the project):iv) Create an annotated bibliography using the “Preparing Annotated Bibliographies (APA 7th)” located in the Student Success Center. https://www.gcumedia.com/lms-resources/student-success-center-content/documents/writing-center/preparing-annotated-bibliographies-apa7-mla8-turabian9.pdf utilizing the five (5) original research articles that support the evidence-based intervention. This will be the foundation of the Literature Synthesis you will have to do in DNP-820A.v) Practice Change Recommendation: Validation of the Chosen Evidence-Based Interventionvi) Summary of the findings written in this section.Problem Statement3) Problem Statement:Describe the variables/groups to project, in one sentence.A well-written problem statement begins with the big picture of the issue ( macro) and works to the small, narrower, and more specific problem ( micro). It clearly communicates the significance, magnitude, and importance of the problem and transitions into the Purpose of the Project with a declarative statement such as: “It is not known if and to what degree/extent…” or “It is not known how/why and….”It is not known if the implementation of __________________would impact_______________ among ___________ (population). PICOT to Evidence-Based Question4) PICOT Question Converts to Evidence-Based Question:(P) Among adult patients in a rural care setting, (I) how does the implementation of a telehealth program (C) compare to traditional commute-for-care ( O) impact rate of follow-up with the primary care provider ( T) over a period of four weeks?https://doi.org/10.1089/dia.2020.0666The study by Gilbert et al. (2021) aimed to assess the changes in HbA1c levels upon using a continuous glucose monitoring system. The recruited patients were two hundred and forty-eight, with sixty having Type 2 Diabetes.The participants were requested to upload their point-of-care HbA1c measurements to an online portal. They then used continuous glucose monitoring devices to monitor their HbA1c values and uploaded them to the portal. Upon data analysis, the researchers noted that there was a significant reduction in the levels of HbA1c levels (p-value <0.001). The HbA1c fell significantly from 8.2% (1.9%) at baseline to 7.1% (1.1%) at the end of the study ( p < 0.001); besides, 54 % of those with initial HbA1c values >7% experienced absolute HbA1c reductions of >1%. This study implied that the improved HbA1c levels among the patients are the results of continuous glucose monitoring. Therefore, this study also indicated the importance of continuous glucose monitoring in improving HbA1c and the management of diabetes.Heinemann, L., Freckmann, G., Ehrmann, D., Faber-Heinemann, G., Guerra, S., Waldenmaier, D., & Hermanns, N. (2018). Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycemia awareness or severe hypoglycemia treated with multiple daily insulin injections (Hypo DE): a multicentre, randomized controlled trial. The Lancet,  391(10128), 1367-1377. https://doi.org/10.1016/S0140-6736(18)30297-6This study was done by Heinemann et al. (2018). This study’s objective was to determine whether real-time continuous glucose monitoring can effectively reduce the severity and incidences of hypoglycemia. In a six-month randomized controlled study, the researchers randomly assigned 75 individuals to a real-time continuous glucose monitoring group, while 74 were assigned to the control groups. The individuals in the real-time continuous glucose monitoring group were taught how to use the monitoring system. They then used real-time continuous monitoring devices for the period of study. On the other hand, the individuals in the control group used glucometer to self-monitor their blood glucose levels at regular intervals during the day. Upon the analysis of the data, it was noted that the individuals in the intervention group reported a significant reduction in hypoglycemic events (p-value of <0.0001). The mean number of hypoglycemic events per month in the continuous glucose monitoring group was reduced from 10·8 (SD 10·0) to 3·5 (4·7); changes in the control group were not significant (from 14·4 [12·4] to 13·7 [11·6]). Incidence of hypoglycemic events decreased by 72% for participants in the continuous glucose monitoring group (incidence rate ratio 0·28 [95% CI 0·20–0·39], p<0·0001). The study implied that the use of continuous glucose monitoring led to a significant reduction in HbA1c levels hence showing the importance of the intervention in diabetes management and care.Martens, T., Beck, R. W., Bailey, R., Ruedy, K. J., Calhoun, P., Peters, A. L., … & MOBILE Study Group. (2021). Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial.  JAMA,  325(22), 2262-2272. doi:10.1001/jama.2021.7444This article presents the findings of the research done by Martens et al. (2021). This study was done with the aim of finding the impacts of continuous glucose monitoring in improving individuals’ HbA1c levels when compared to the impact of blood glucose meter monitoring. In a randomized controlled trial, these researchers recruited a total of 175 people with type 2 diabetes. While the individuals in the intervention group used continuous glucose monitoring, the ones in the control group engaged in blood glucose meter monitoring. This study was done for a period of eight months. Upon analyzing the data, it was noted that the individuals in the intervention group showed a substantial reduction in HbA1c levels (p-value of 0.02). There was also a significant difference between the intervention and control groups (p-value of 0.001). Mean HbA1c level decreased from 9.1% at baseline to 8.0% at eight months in the continuous glucose monitoring group and from 9.0% to 8.4% in the control group (adjusted difference, −0.4% [95% CI, −0.8% to −0.1%]; p= 0.02). The results imply that continuous glucose monitoring leads to a more significant reduction in HbA1c levels, indicating that the intervention is effective.Grace, T., & Salyer, J. (2022). Use of Real-Time Continuous Glucose Monitoring Improves Glycemic Control and Other Clinical Outcomes in Type 2 Diabetes Patients Treated with Less Intensive Therapy.  Diabetes Technology & Therapeutics,  24(1), 26-31. DOI: 10.1089/dia.2021.0212.Authored by Grace & Salyer (2022), this study focused on using real-time continuous glucose monitoring in the management of patients with diabetes type to improve glycemic control. The researchers recruited patients with type 2 diabetes with basal insulin only or noninsulin therapy. At six months, the researcher found relevant outcomes. For example, the participants showed a considerable reduction in HbA1c levels (−3.0% ± 1.3%, p-value <0.001). In addition, the researchers observed a reduction in the average levels of glucose at six months (−23.6 ± 38.8,  P < 0.001). Therefore, continuous glucose monitoring was connected with significant glycemic improvements among patients with type 2 diabetes.v. Practice Change Recommendation: Validation of the Chosen Evidence-Based InterventionThe standards of diabetes care have been used at the facility for years as a preference. However, this approach has not been as effective as expected. As such, this research proposes to investigate whether the increased prescription of continuous glucose monitoring as an intervention to help patients with type 2 diabetes have improved HbA1c levels, as shown in the research done by Beck et al. (2017). In a randomized controlled trial, the researchers randomized (n=79) patients in a continuous glucose monitoring group while (n=79) were in the control group. The continuous glucose monitoring group used a Dexcom G4 platinum continuous monitoring system to monitor their glucose concentrations to give a better reduction in HbA1c levels as compared to the control group (p values of 0.022). The analysis of the study findings showed that the mean HbA1c levels went down to 7.7 % and 8.0% in the continuous glucose monitoring group and control group, respectively (adjusted difference in mean change, −0.3% [95% CI, −0.5% to 0.0%]; P = 0.022), showing that the intervention was efficacious (Beck et al.,2017). As such, this randomized controlled trial study shows that continuous glucose monitoring can effectively improve HbA1c levels among patients with type 2 diabetes hence a recommendation for practice change (Beck et al., 2017).vi. Summary of the findings written in this section.Diabetes is one of the most common and disabling chronic conditions. However, the application of nursing interventions can be key to improving patient outcomes (Beck et al., 2017). From the annotations, it is evident that the use of continuous glucose monitoring as an intervention in managing diabetes leads to a better control in patient’s blood glucose, even though the cost of purchasing it is significantly higher. For example, the researchers reported significant improvement in the HbA1c levels upon the use of continuous glucose monitoring. When the results for the control groups were compared with intervention groups, significant improvements among the intervention groups were observed. For example, the reduction in the HbA1 levels observed between the intervention and control group by Beck et al. (2017) was significant (p= 0.022); Gilbert et al. (2021) observed ( p < 0.001), Heinemann et al. (2019) observed ( p < 0.001); Martens et al. (2021) also observed ( p < 0.001); Grace & Salyer observed (p <0.001)Problem Statement3) Problem Statement:Describe the variables/groups to project in one sentence.It is not known if the implementation of the translation of research by Beck et al. (2017) on continuous glucose monitoring to improve the rate of practitioners’ ordering continuous glucose monitoring would impact HbA1c levels among patients with type II diabetes. PICOT to Evidence-Based Question4) PICOT Question Converts to Evidence-Based Question:Among adult patients with type 2 diabetes in an outpatient clinic, will the translation of Beck et al.’s research on continuous glucose monitoring increase the rate of practitioners ordering continuous glucose monitoring impact HgbA1C compared to current practice in 12 weeks?https://doi.org/10.1089/dia.2020.0666Glasofer, A., & Townsend, A. B. (2021). Determining the level of evidence. Nursing, 51(2), 62–65. https://doi.org/10.1097/01.nurse.0000731852.39123.e1Grace, T., & Salyer, J. (2022). Use of Real-Time Continuous Glucose Monitoring Improves Glycemic Control and Other Clinical Outcomes in Type 2 Diabetes Patients Treated with Less Intensive Therapy.  Diabetes Technology & Therapeutics,  24(1), 26-31. https://doi.org/10.1089/dia.2021.0212.Haque, W. Z., Demidowich, A. P., Sidhaye, A., Golden, S. H., & Zilbermint, M. (2021). The Financial Impact of an Inpatient Diabetes Management Service.  Current Diabetes Reports,  21(2), 1-9. https://doi.org/10.1007/s11892-020-01374-0.Heinemann, L., Freckmann, G., Ehrmann, D., Faber-Heinemann, G., Guerra, S., Waldenmaier, D., & Hermanns, N. (2018). Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycemia awareness or severe hypoglycemia treated with multiple daily insulin injections (Hypo DE): a multicentre, randomized controlled trial. The Lancet,  391(10128), 1367-1377. https://doi.org/10.1016/S0140-6736(18)30297-6Hussain, S. T., Lei, S., Akram, T., Haider, M. J., Hussain, S. H., & Ali, M. (2018). Kurt Lewin’s change model: A critical review of the role of leadership and employee involvement in organizational change.  Journal of Innovation & Knowledge,  3(3), 123-127. https://doi.org/10.1016/j.jik.2016.07.002Khan, R. M. M., Chua, Z. J. Y., Tan, J. C., Yang, Y., Liao, Z., & Zhao, Y. (2019). From pre-diabetes to diabetes: diagnosis, treatments, and translational research. Medicina,  55(9), 546. https://doi.org/10.3390/medicina55090546Maiorino, M. I., Signoriello, S., Maio, A., Chiodini, P., Bellastella, G., Scappaticcio, L., … & Esposito, K. (2020). Effects of continuous glucose monitoring on metrics of glycemic control in diabetes: a systematic review with meta-analysis of randomized controlled trials.  Diabetes Care,  43(5), 1146-1156. https://doi.org/10.2337/dc19-1459Martens, T., Beck, R. W., Bailey, R., Ruedy, K. J., Calhoun, P., Peters, A. L., … & MOBILE Study Group. (2021). Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial.  JAMA,  325(22), 2262-2272. https://doi:10.1001/jama.2021.7444Orem, D. E., & Calnan, M. E. (1972). NURSING. Nursing Management (Springhouse), 3(1), 43-46. https://doi.org/10.1097/00006247-197201000-00013Root, A., Connolly, C., Majors, S., Ahmed, H., & Toma, M. (2022). Electronic blood glucose monitoring impacts on provider and patient behavior.  Journal of the American Medical Informatics Association. https://doi.org/10.1093/jamia/ocac069Skinner, T. C., Joensen, L., & Parkin, T. (2020). Twenty‐five years of diabetes distress research.  Diabetic Medicine,  37(3), 393-400.  https://doi.org/10.1111/dme.14157.

The post DNP- 10 Strategic Points appeared first on Essay Writing Service Best Prices | Top Grades | StudyAffiliates.